Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mehtali

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Gene Therapy|December 8, 2000
A preclinical model of hepatocyte gene transfer: the in vivo, in situ perfused rat liverJ L De Godoy, R Malafosse, M Fabre, et al.
Virus Research|November 14, 2000
Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3P S Reddy, N Idamakanti, L N Zakhartchouk, et al.
Journal of Virology|October 9, 1999
Replication-defective bovine adenovirus type 3 as an expression vectorP S Reddy, N Idamakanti, Y Chen, et al.
Gene Therapy|December 1, 1996
Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2F Quintin-Colonna, P Devauchelle, D Fradelizi, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1989
Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milkC Tomasetto, C Wolf, M C Rio, et al.
Immunology Letters|June 1, 1997
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune responseM Christ, M Lusky, F Stoeckel, et al.
Human Gene Therapy|June 1, 1995
Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenovirusesJ L Imler, A Bout, D Dreyer, et al.
Gene Therapy|June 13, 2001
Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropismP Leissner, V Legrand, Y Schlesinger, et al.
Gene Therapy|January 1, 1996
Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectorsJ L Imler, C Chartier, D Dreyer, et al.
The Journal of Gene Medicine|February 24, 2001
Differential influence of the E4 adenoviral genes on viral and cellular promotersL Grave, D Dreyer, A Dieterle, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Gene Therapy|December 8, 2000
A preclinical model of hepatocyte gene transfer: the in vivo, in situ perfused rat liverJ L De Godoy, R Malafosse, M Fabre, et al.
Virus Research|November 14, 2000
Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3P S Reddy, N Idamakanti, L N Zakhartchouk, et al.
Journal of Virology|October 9, 1999
Replication-defective bovine adenovirus type 3 as an expression vectorP S Reddy, N Idamakanti, Y Chen, et al.
Gene Therapy|December 1, 1996
Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2F Quintin-Colonna, P Devauchelle, D Fradelizi, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1989
Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milkC Tomasetto, C Wolf, M C Rio, et al.
Immunology Letters|June 1, 1997
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune responseM Christ, M Lusky, F Stoeckel, et al.
Human Gene Therapy|June 1, 1995
Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenovirusesJ L Imler, A Bout, D Dreyer, et al.
Gene Therapy|June 13, 2001
Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropismP Leissner, V Legrand, Y Schlesinger, et al.
Gene Therapy|January 1, 1996
Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectorsJ L Imler, C Chartier, D Dreyer, et al.
The Journal of Gene Medicine|February 24, 2001
Differential influence of the E4 adenoviral genes on viral and cellular promotersL Grave, D Dreyer, A Dieterle, et al.
Pageof 7